無菌試験の世界市場予測（～2021）：装置、サービス、キット、試薬...市場調査レポートについてご紹介

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 24)

4 Premium Insights (Page No. – 28)
4.1 Significant Opportunities in the Sterility Testing Market
4.2 Geographic Analysis: Sterility Testing Market, By Product (2016)
4.3 Geographic Snapshot of the Market

5 Market Overview (Page No. – 31)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growth of Pharmaceutical & Biotechnology Companies
5.2.1.2 Increasing Number of Drug Launches
5.2.1.3 Government Support for Pharmaceutical and Biotechnology Industries
5.2.1.4 Increasing R&D Investments in Life Sciences
5.2.2 Restraints
5.2.2.1 High Degree of Consolidation, A Major Barrier for New Market Entrants
5.2.2.2 Stringent Regulatory Frameworks and Time-Consuming Approval Processes
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Increasing Pharmaceutical Outsourcing
5.2.4 Challenge
5.2.4.1 Shortage of Skilled Professionals
5.3 Porter’s Five Forces Analysis
5.4 Supply Chain Analysis

6 Sterility Testing Market, By Product (Page No. – 38)
6.1 Introduction
6.2 Kits & Reagents
6.3 Services
6.4 Instruments

7 Sterility Testing Market, By Test (Page No. – 42)
7.1 Introduction
7.2 Membrane Filtration
7.3 Direct Inoculation
7.4 Other Tests

8 Sterility Testing Market, By Application (Page No. – 47)
8.1 Introduction
8.2 Pharmaceutical and Biological Manufacturing
8.3 Medical Device Manufacturing
8.4 Other Applications

9 Sterility Testing Market, By Region (Page No. – 52)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe (RoE)
9.4 Asia
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia
9.5 Rest of the World
9.5.1 South America, Central America, and the Caribbean
9.5.2 Pacific and Oceania
9.5.3 Africa

10 Competitive Landscape (Page No. – 88)
10.1 Overview
10.2 Strategic Overview
10.3 Market Share Analysis
10.4 Competitive Situation and Trends
10.4.1 Expansions
10.4.2 Mergers & Acquisitions
10.4.3 Agreements, Partnerships, and Collaborations
10.4.4 Product Launches

11 Company Profiles (Page No. – 95)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Merck KGaA
11.3 Charles River Laboratories International, Inc.
11.4 Biomérieux SA
11.5 SGS S.A.
11.6 Danaher Corporation
11.7 Nelson Laboratories
11.8 Pacific Biolabs
11.9 Sartorius AG
11.10 Thermo Fisher Scientific Inc.
11.11 Toxikon Corporation
11.12 Wuxi Apptec

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 116)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details